Home > Insider Trading > Filing (0001225208-14-022489)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1372915	C Ian Read	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	Chairman & Ceo	Yes	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2014-10-30	54,585	$17.03	1,465,906	No	4	M	Direct
Common Stock	Disposition	2014-10-30	15,375	$29.84	1,450,531	No	4	F	Direct
Common Stock	Disposition	2014-10-30	24,169	$28.75	1,426,362	No	4	F	Direct
Common Stock	Disposition	2014-10-30	67,500	$29.76	1,358,862	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	F	Direct
No	4	F	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2014-10-30	54,585	$0.00	54,585	$17.03
Common Stock	Phantom Stock Units SSP	Acquisiton	2014-10-31	153	$29.95	153	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2014-10-30	2014-10-30	No	4	M	Direct
176,351			No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	9,785	Indirect	By Rule 16b-3 Plan
Common Stock	33,809	Indirect	By Trust

Footnotes

The reported transaction constitutes the earn-out of stock appreciation rights (including dividend equivalents thereon).
The reported transaction constitutes the withholding of shares to satisfy tax obligations in connection with earn-out of stock appreciation rights.
The reported transaction constitutes the withholding of shares to cover payment of exercise price in connection with earn-out of stock appreciation rights (including dividend equivalents thereon).
Under the terms of the settlement of the stock appreciation rights the 20-day average of the closing prices of Pfizer common stock ending on the settlement date is used.
In accordance with the provisions of his Grantor Retained Annuity Trust (GRAT), 27,800 shares were transferred from the GRAT to the reporting person's direct ownership on September 17, 2014.
Each unit represents one phantom share of common stock.
These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service and may be transferred by the reporting person into an alternative investment account at any time.